AKYLA/ Financials
MarketsScreenerFinancialsResearchChat
Equity / PHARMACEUTICAL PREPARATIONS
Clene Inc. Common Stock
XNAS · usd
SIC 2834 · PHARMACEUTICAL PREPARATIONS
FIGI BBG00X3GTK84
3.88▲ 0.00 (0.00%)
As of 2026-10-23
Price / Volume
Valuation
Market Cap
Enterprise Value
Trailing P/E
—
Price / Sales
EV / Revenue
EV / EBITDA
Financial Highlights
Revenue (TTM)
Net Income (TTM)
EBITDA
Diluted EPS (TTM)
EBITDA Margin
Net Debt
Trading Information
Previous Close
3.88
Day's Range
3.77 – 3.97
52-Week Range
3.02 – 13.50
Volume
20.9K
Avg Volume
120.6K
Share Statistics
Shares Outstanding
Employees
79
Exchange
XNAS
Listed
2020-12-31
Share count as of August 11, 2026

Clene Inc. Common Stock (CLNN) Financial Statements

View
Income Statement
Detail
Standard
Period
Quarterly
Loading Income Statement…
Key questions about Clene Inc. Common Stock (CLNN)
What is Clene Inc. Common Stock's Market Cap?
Clene Inc. Common Stock's Market Cap is $49.9M, based on as-reported figures from SEC (XBRL) filings.
What is Clene Inc. Common Stock's Enterprise Value?
Clene Inc. Common Stock's Enterprise Value is $57.8M, based on as-reported figures from SEC (XBRL) filings.
What is Clene Inc. Common Stock's Price / Sales?
Clene Inc. Common Stock's Price / Sales is 253.1×, based on as-reported figures from SEC (XBRL) filings.
What is Clene Inc. Common Stock's EV / Revenue?
Clene Inc. Common Stock's EV / Revenue is 293.3×, based on as-reported figures from SEC (XBRL) filings.
What is Clene Inc. Common Stock's EV / EBITDA?
Clene Inc. Common Stock's EV / EBITDA is n/m, based on as-reported figures from SEC (XBRL) filings.
What is Clene Inc. Common Stock's Revenue (TTM)?
Clene Inc. Common Stock's Revenue (TTM) is $197.0K, based on as-reported figures from SEC (XBRL) filings.
What is Clene Inc. Common Stock's Net Income (TTM)?
Clene Inc. Common Stock's Net Income (TTM) is -$39.5M, based on as-reported figures from SEC (XBRL) filings.
What is Clene Inc. Common Stock's EBITDA?
Clene Inc. Common Stock's EBITDA is -$19.1M, based on as-reported figures from SEC (XBRL) filings.
What is Clene Inc. Common Stock's Diluted EPS (TTM)?
Clene Inc. Common Stock's Diluted EPS (TTM) is -3.08, based on as-reported figures from SEC (XBRL) filings.
What is Clene Inc. Common Stock's EBITDA Margin?
Clene Inc. Common Stock's EBITDA Margin is -9704.6%, based on as-reported figures from SEC (XBRL) filings.
Akyla / Financials · CLNNAs-filed SEC (XBRL) data
Showing the most recent year. Subscribe for full statement history.
Income Statement(in USD, except per-share data)
Source: Akyla.ai
Line ItemJun 30, 2026Mar 31, 2026Dec 31, 2025Sep 30, 2025Jun 30, 2025Mar 31, 2025Dec 31, 2024Sep 30, 2024Jun 30, 2024Mar 31, 2024Dec 31, 2023Sep 30, 2023Jun 30, 2023Mar 31, 2023Dec 31, 2022Sep 30, 2022
Revenue:
Total revenue
YoY growth+233.3%-81.5%-15.4%-82.8%
Operating expenses:
Cost of revenue
Research and development
General and administrative
Total operating expenses
% of revenue6041.1%13840.0%9833.8%37753.3%
Loss from operations
% of revenue-5941.1%-13740.0%-9733.8%-37653.3%
Other income (expense), net:
Interest income
Interest expense
Issuance costs for common stock warrant liabilities——
Loss on initial issuance of equity——
Change in fair value of common stock warrant liabilities
Change in fair value of derivative liabilities
Research and development tax credits and unrestricted grants
Total other income (expense), net
Net loss before income taxes
Net loss
% of revenue-14915.6%-53940.0%-11981.8%-58513.3%
Net loss per share – basic and diluted (in dollars per share)